Suppr超能文献

组织学检查淋巴结阴性的食管鳞状细胞癌的预后

Outcome of histologically node-negative esophageal squamous cell carcinoma.

作者信息

Tabira Yoichi, Yasunaga Masahiro, Sakaguchi Tomonori, Yamaguchi Yuji, Okuma Toshiyuki, Kawasuji Michio

机构信息

Department of Surgery I, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto 860-8556, Japan.

出版信息

World J Surg. 2002 Dec;26(12):1446-51. doi: 10.1007/s00268-002-6415-4. Epub 2002 Sep 26.

Abstract

The outcome of node-negative esophageal carcinoma and the prognostic significance of lymph node micrometastasis remain unknown. The aim of this retrospective study was to clarify these two points. A series of 98 patients who underwent curative operation for histologically node-negative (pN0 in TNM classification) esophageal carcinoma were enrolled in the study. We reviewed the cause of death of these patients. The survival curves were calculated and compared after stratifications according to clinicopathologic parameters. Lymph node micrometastasis in the patients with recurrences was examined using immunohistochemical staining of cytokeratin. Their ages ranged from 45 to 83 years (mean 64.3 years). There were 83 men and 15 women. Altogether, 54 patients were still alive, and 44 had died. A total of 9 patients died from recurrence of their esophageal carcinoma, 33 died from other causes (pneumonia 11, extraesophageal carcinoma 7, and so on), and 2 died from unknown causes. Eight patients had locoregional recurrences, and two patients had distant recurrences. The overall survival rate for the 98 patients was 58.2%. The survival for patients with pT2 or pT3 tumors was significantly worse than for those with pTis or pT1 tumors (p = 0.02, log-rank test). Other clinicopathologic factors did not affect the prognosis. Immunohistochemical study found no lymph node micrometastasis in 365 lymph nodes resected from the patients with recurrences. Only the depth of tumor invasion affected the outcome of patients with node-negative esophageal carcinoma. Altogether, 75% of patients died of other causes without recurrence, with the two main causes of death being pulmonary complications and extraesophageal carcinoma in these patients. Lymph node micrometastasis was not associated with recurrence in this series.

摘要

淋巴结阴性食管癌的预后以及淋巴结微转移的预后意义尚不清楚。本回顾性研究的目的是阐明这两点。本研究纳入了98例经组织学检查为淋巴结阴性(TNM分类为pN0)的食管癌患者,这些患者均接受了根治性手术。我们回顾了这些患者的死亡原因。根据临床病理参数进行分层后,计算并比较了生存曲线。对复发患者的淋巴结微转移情况采用细胞角蛋白免疫组化染色进行检测。患者年龄在45至83岁之间(平均64.3岁),男性83例,女性15例。共有54例患者存活,44例患者死亡。共有9例患者死于食管癌复发,33例死于其他原因(肺炎11例,食管外癌7例等),2例死因不明。8例患者出现局部复发,2例患者出现远处复发。98例患者的总生存率为58.2%。pT2或pT3肿瘤患者的生存率明显低于pTis或pT1肿瘤患者(p = 0.02,对数秩检验)。其他临床病理因素不影响预后。免疫组化研究发现,复发患者切除的365枚淋巴结中未发现淋巴结微转移。只有肿瘤浸润深度影响淋巴结阴性食管癌患者的预后。总之,75%的患者死于其他原因而未复发,这些患者的两个主要死亡原因是肺部并发症和食管外癌。在本系列研究中,淋巴结微转移与复发无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验